The values provided in this updated report are substantially higher than those calculated in the previous report (328,300 and 228,300 GBP per QALY gained for 5 and 10 years respectively). It can be inferred therefore that the validity of the previous conclusions, which stated that therapy produces small short-term gains for large additional costs, are further strengthened as a result of incorporating new trial evidence.